Liquidia Corp 4

Dr. Stephen M. Bloch (via Canaan VIII L.P.) sold 78,596 shares of Liquidia Corp (LQDA) common stock in open‑market transactions totaling approximately $6.3 million.

On July 20 and 21, 2026, reporting person Dr. Stephen M. Bloch, in his capacity related to Canaan VIII L.P., reported open‑market sales of Liquidia Corp common stock totaling 78,596 shares at weighted average prices around $79.55–$80.66 per share, for aggregate proceeds of roughly $6.3 million. The sales were executed in multiple trades within stated price ranges, and after these transactions the indirect holdings attributed to Bloch (through the Canaan entities) decreased from 776,477 to 701,477 shares, while a separate direct position of 71,594 shares is also disclosed. The securities are held by Canaan VIII L.P., with Canaan Partners VIII LLC as its general partner, and Bloch disclaims beneficial ownership beyond his pecuniary interest; investment and voting decisions are made collectively by the managers of Canaan Partners VIII LLC under a communications‑screen policy, and the filing notes that Bloch did not participate in the specific investment decisions for these sales.

Filing Facts

CIK

1819576

Ticker

LQDA

Form

4

Source Type

fda

Accession

0001104659-26-085979

Alert Tier

7